Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl in Biliary Tract Cancer

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing